Showing 1 - 5 results of 5 for search 'Vikas V Dukhande', query time: 0.03s Refine Results
  1. 1
    Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy

    Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy by Aishwarya Saraswat, Hari Priya Vemana, Vikas V. Dukhande, Ketan Patel

    Published 2022-01-01
    Get full text
    Article
  2. 2
    EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF<sup>V600E</sup> Mutated Parent- and Vemurafenib-Resistant Melanoma

    EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF<sup>V600E</sup> Mutated Parent- and Vemurafenib-Resistant Melanoma by Yige Fu, Drishti Rathod, Ehab M. Abo-Ali, Vikas V. Dukhande, Ketan Patel

    Published 2019-10-01
    Get full text
    Article
  3. 3
    Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts

    Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts by James C K Lai, Maria B Lai, Sirisha Jandhyam, Vikas V Dukhande, Alok Bhushan, et al

    Published 2008-12-01
    Get full text
    Article
  4. 4
    Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma

    Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma by Yige Fu, Aishwarya Saraswat, Zenghui Wei, Manas Yogendra Agrawal, Vikas V. Dukhande, Sandra E. Reznik, Ketan Patel

    Published 2021-07-01
    Get full text
    Article
  5. 5
    Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.

    Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. by Vikas V Dukhande, Devin M Rogers, Carlos Romá-Mateo, Jordi Donderis, Alberto Marina, Adam O Taylor, Pascual Sanz, Matthew S Gentry

    Published 2011-01-01
    Get full text
    Article

Search Tools: